NDC 13537-810-01 - ESIKA HYDRACOLOR 2 IN 1 HIGHLY MOISTURIZING AND Coloring SPF 25 (PIMIENTA CALIENTE) - BROWN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13537-810
- Requested NDC
- 13537-810-01
- Package NDCs from labels
- 13537-810-01, 13537-810-02
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2016-11-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OCTINOXATE and OXYBENZONE - Ventura Corporation LTD | Bel Star S.A. (Colombia) | Ventura Corporation LTD | Bel Star S.A. (Colombia) | 2016-11-09 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-810-02 | 2025-04-03 | C162847 | 48780-1 | 9d75b9d0-3511-f424-e053-dadaa90a57ce | ÉSIKA HYDRACOLOR 2 IN 1 HIGHLY MOISTURIZING AND COLORING LIPSTICK SPF 25 |
| 13537-810-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3511-f424-e053-dadaa90a57ce | ÉSIKA HYDRACOLOR 2 IN 1 HIGHLY MOISTURIZING AND COLORING LIPSTICK SPF 25 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride in Lactated Ringers and Dextrose | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | 05f326e6-10e4-4ceb-8a23-f53c592f00b8 | 2025-10-29 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | ICU Medical Inc. | 189b8ac6-e346-454f-b501-7645590ca4f8 | 2025-10-29 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X 660YQ98I10 |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 6acc9f96-7088-45a7-b48f-1a861e3467ab | 2025-10-29 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Lactated Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | Baxter Healthcare Company | dad7735c-709b-40ea-ab7a-15577e24a966 | 2025-10-29 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | ICU Medical Inc. | eb56a807-ea94-4edb-9811-a04b19568468 | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 660YQ98I10 |
| WALMART SALINE | SALINE NASAL (SODIUM CHLORIDE) | WALMART STORES INC | 06906744-49a5-4bab-8539-af2d235df9e8 | 2025-10-28 | Warnings | 451W47IQ8X |
| Perricone MD Neuropeptide Restorative Neck and Chest Therapy Broad Spectrum SPF 25 | TITANIUM DIOXIDE | THG Beauty USA LLC | 23f4cf41-0eed-2df3-e063-6294a90ad402 | 2025-10-28 | Warnings | 15FIX9V2JP |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | PDC6A3C0OX |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | PDC6A3C0OX |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Premier Brands of America, Inc. | d3452573-f91f-f157-e053-2a95a90a1ad8 | 2025-10-27 | Warnings | 1K09F3G675 |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | aad6e18f-04f8-4799-b366-873ec5a50317 | 2025-10-27 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.